Skip to main content

WHO dumps hydroxychloroquine as drug for coronavirus

The World Health Organisation has announced that it has suspended a clinical trial of the anti-malaria drug, hydroxychloroquine in coronavirus patients.

The UN agency said it did so out of safety concerns.

It said it was concerned about safety of the drug, after a study from The Lancet revealed higher mortality rates among COVID-19 patients who took the drugs.

“The authors reported that among #COVID19 patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate”, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.

He said hydroxychloroquine and chloraquine drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria.

Hydroxychloroquine has been touted by President Donald Trump as a cure for coronavirus.

He even revealed he took the medication for two weeks as prophylactic

Read Tedros full statement below:

On Friday, The Lancet published an observational study on hydroxycholoroquine & chloraquine and its effects on COVID-19 patients that have been hospitalised.
“The authors reported that among #COVID19 patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate.

“The Executive Group of the Solidarity Trial, representing 10 of the participating countries, met on Saturday and has agreed to review a comprehensive analysis and critical appraisal of all evidence available globally.

“The review will consider data collected so far in the Solidarity Trial and, in particular robust randomised available data, to adequately evaluate the potential benefits and harms from this drug

“The Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the data is reviewed by the Data Safety Monitoring Board.

“The other arms of the trial are continuing.

“This concern relates to the use of hydroxychloroquine and chloraquine in #COVID19.

“I wish to reiterate that these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria.

“WHO will provide further updates as we know more.

“And we will continue to work night and day for solutions, science and solidarity”




Comments

Post a Comment

Popular posts from this blog

Kenyan Law Court dismisses case of man seeking compensation after his wife eloped with another man from hospital

  A lawsuit filed by a man seeking to be compensated by St Mary's Mission Hospital in Kenya for allowing his wife to leave the hospital with another man after giving birth, has been struck out by a law court.    The appellant had sued the St. Mary's Mission hospital at Kakamega law courts in 2020 seeking general damages from the facility on grounds that the hospital had discharged his wife and allowed her to leave with another man. After delivering and at the time of discharge, the wife of the appellant claimed he was the baby's father.   The court of appeal judges Patrick Kiage, Mumbi Ngugi and Francis Tuiyott sitting at the Kisumu Court of Appeal, empathized with the man, but disagreed that he (the appellant) be compensated by the hospital for not detaining his wife.  They upheld the lower court's judgement which added that there's no remedy that lies in the law for such grievances.   Kiage said;   "I agree that if a man takes the woman he loves to t...
Post a Comment
Read more

Hurricane Hits Texas, One Person Reported Dead

Hurricane Harvey hit Texas as a Category 4 storm on Friday, battering the coast with 130-mph winds and torrential rain. It was the strongest hurricane to hit the United States in more than a decade leaving a massive destruction, loss of electricity, wrecked buildings and has so far killed at least one person. Scroll down to see more pictures of the incident:
Post a Comment
Read more

Floyd Mayweather backs out of fight with 20-year-old kickboxer after receiving bashing from 50 Cent and others

American professional boxer, Floyd Mayweather, has dramatically made a U-Turn and won't be fighting 20-year-old Japanese kickboxer,Tenshin Nasukawa anymore for his comeback fight. The 41-year-old had initially confirmed the bout for 31st of December 2018 during a press conference which took place on Sunday night in Tokyo. It was also understood that he revealed that he signed with Japanese mixed martial arts promotions company RIZIN Fighting Federation. After the announcement, his enemies, 50 Cent, Conor McGregor and many others blasted him for agreeing to fight a younger kickboxer. Taking to his Instagram account this night, Mayweather denied he agreed to an official bout with Tenshin Nasukawa. He wrote:  Now that I am back on U.S. soil after a long and disappointing trip to Tokyo, I now have the time to address you, my fans and the media in regard to the upcoming event on December 31st that was recently announced. First and foremost, I want it to be clear that I, F...
Post a Comment
Read more